AI devices with FDA product code QWZ — Prognostic Test For Assessment Of Chronic Kidney Disease Progression

Product code QWZ (“Prognostic Test For Assessment Of Chronic Kidney Disease Progression” in openFDA) covers 1 device on the FDA AI-enabled list, from 1 company. Most are reviewed by the Clinical Chemistry panel (1). The most recent decision was KidneyIntelX.dkd on June 29, 2023.